Prova Education: Changing the Practice of Medicine

Changing the Practice of Medicine

Discover CME, tools, and guideline-focused education to
improve your knowledge - and patient outcomes.

Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
MinuteCE®
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer
0.50 program credits
- Joyce F. Liu, MD, MPH
0.50 program credits
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
MinuteCE®
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies
0.50 program credits
- Joyce F. Liu, MD, MPH
0.50 program credits
MOA: CDH6-Targeted Antibody-Drug Conjugates
MOA: CDH6-Targeted Antibody-Drug Conjugates
MinuteCE®
MOA: CDH6-Targeted Antibody-Drug Conjugates
0.50 program credits
- Kathleen Moore, MD, MS
0.50 program credits
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
CME/CE
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need
0.25 credits
- Naim Alkhouri, MD, FAASLD, DABOM
0.25 credits
Screening for Cervical Cancer
Screening for Cervical Cancer
MinuteCE®
Screening for Cervical Cancer
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit
Evidence- and Guideline-Based Treatment for High-Risk Locally Advanced Cervical Cancer
Evidence- and Guideline-Based Treatment for High-Risk Locally Advanced Cervical Cancer
MinuteCE®
Evidence- and Guideline-Based Treatment for High-Risk Locally Advanced Cervical Cancer
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit
Case Applications in Multidisciplinary Care for Endometrial Cancer
Case Applications in Multidisciplinary Care for Endometrial Cancer
MinuteCE®
Case Applications in Multidisciplinary Care for Endometrial Cancer
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit
Role of Predictive Biomarkers in Endometrial Cancer
Role of Predictive Biomarkers in Endometrial Cancer
MinuteCE®
Role of Predictive Biomarkers in Endometrial Cancer
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit

CME/CE

MinuteCE®
CDH6 in Focus: Advancing Biomarker-Driven Strategies for Platinum-Resistant Ovarian Cancer
0.50 credits 5 episodes
- Kathleen Moore, MD, MS
- Joyce F. Liu, MD, MPH
0.50 credits 5 episodes
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
CME/CE
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach
0.25 credits
- Christyn Edmundson, MD
- Neelam Goyal, MD
0.25 credits
MinuteCE®
Innovations in Precision Medicine: Leveraging Guideline-Based Immunotherapy and Targeted Treatments in Gynecologic Oncology
1.00 credit 10 episodes
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 credit 10 episodes
Evidence- and Guideline-Based Treatment for Advanced/Metastatic Cervical Cancer
Evidence- and Guideline-Based Treatment for Advanced/Metastatic Cervical Cancer
MinuteCE®
Evidence- and Guideline-Based Treatment for Advanced/Metastatic Cervical Cancer
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit
Evidence Base for First-Line Treatment Strategies for Endometrial Cancer and Delivering Guideline-Concordant Care
Evidence Base for First-Line Treatment Strategies for Endometrial Cancer and Delivering Guideline-Concordant Care
MinuteCE®
Evidence Base for First-Line Treatment Strategies for Endometrial Cancer and Delivering Guideline-Concordant Care
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit
Managing Immune-Related Adverse Events in Cervical and Endometrial Cancer
Managing Immune-Related Adverse Events in Cervical and Endometrial Cancer
MinuteCE®
Managing Immune-Related Adverse Events in Cervical and Endometrial Cancer
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit

Clinical Practice

Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
MinuteCE®
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates
0.50 program credits
- Kathleen Moore, MD, MS
0.50 program credits
Pruritus In PN and AD: Challenge How You Manage Itch
Pruritus In PN and AD: Challenge How You Manage Itch
CME/CE
Pruritus In PN and AD: Challenge How You Manage Itch
1.00 credit
- Peter A. Lio, MD
1.00 credit
Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation in Locally Advanced HNSCC: First Results From the Randomized Phase 2b ADRISK Trial
Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation in Locally Advanced HNSCC: First Results From the Randomized Phase 2b ADRISK Trial
Oncology and Hematology
Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation in Locally Advanced HNSCC: First Results From the Randomized Phase 2b ADRISK Trial
- Yungan Tao
Cohort 9 of the Phase 2 EV-202 Trial: First-Line Enfortumab Vedotin Plus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Cohort 9 of the Phase 2 EV-202 Trial: First-Line Enfortumab Vedotin Plus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Oncology and Hematology
Cohort 9 of the Phase 2 EV-202 Trial: First-Line Enfortumab Vedotin Plus Pembrolizumab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Paul L Swiecicki, MD
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 
MinuteCE®
Rethinking the Therapeutic Targeting of B7-H3 in ES-SCLC 
0.50 program credits
- Lauren A. Byers, MD
0.50 program credits
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
MinuteCE®
Emerging Clinical Evidence for B7-H3–Directed ADCs in ES-SCLC From WCLC 2025
0.50 program credits
- Luis Paz-Ares, MD, PhD
- Lauren A. Byers, MD
0.50 program credits

Programs

Interdisciplinary Management of Gynecologic Cancers
Interdisciplinary Management of Gynecologic Cancers
MinuteCE®
Interdisciplinary Management of Gynecologic Cancers
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit
Applications in Multidisciplinary Care for Cervical Cancer
Applications in Multidisciplinary Care for Cervical Cancer
MinuteCE®
Applications in Multidisciplinary Care for Cervical Cancer
1.00 program credit
- Brian Slomovitz, MD
- Casey Cosgrove, MD
- Michelle Flint, WHNP-BS
1.00 program credit
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
CME/CE
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
0.50 credits
- Neelam Goyal, MD
- Christyn Edmundson, MD
0.50 credits
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
MinuteCE®
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
0.75 program credits
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
MinuteCE®
Double Take: Pivotal Data Evaluating PI3K Inhibitor/Endocrine Therapy Regimens in mBC
0.75 program credits
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
MinuteCE®
Comprehensive Biomarker Testing in mBC Informs Clinical Decision Making
0.75 program credits
- Komal Jhaveri, MD, FACP
- Kevin Kalinsky MD, MS
0.75 program credits

Changing the Practice of Medicine

Popular

CME/CE

Clinical Practice

Programs

Title

Share on ReachMD